These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 11605546

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Newcastle disease virus heredity mutation and correlation of HN and F gene].
    Qin ZM, Ma BC, He YF, Wang YL, Cui ZZ.
    Wei Sheng Wu Xue Bao; 2006 Apr; 46(2):227-32. PubMed ID: 16736582
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Temperature-sensitive mutants of Newcastle disease virus altered in HN glycoprotein size, stability, or antigenic maturity.
    Peeples ME, Glickman RL, Gallagher JP, Bratt MA.
    Virology; 1988 May; 164(1):284-9. PubMed ID: 3363869
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Increase in the neuraminidase activity of a nonpathogenic Newcastle disease virus isolate during passaging in chickens.
    Tsunekun R, Ito H, Kida H, Otsuki K, Ito T.
    J Vet Med Sci; 2010 Apr; 72(4):453-7. PubMed ID: 20009427
    [Abstract] [Full Text] [Related]

  • 30. [Cloning of F gene of Newcastle disease virus HeB02 isolate and the study of its DNA vaccine].
    Li N, Sun YM, Zhao BH.
    Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):445-50. PubMed ID: 16755925
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus.
    Schirrmacher V, Haas C, Bonifer R, Ahlert T, Gerhards R, Ertel C.
    Gene Ther; 1999 Jan; 6(1):63-73. PubMed ID: 10341877
    [Abstract] [Full Text] [Related]

  • 33. Antitumor vaccination by Newcastle Disease Virus Hemagglutinin-Neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity.
    Ni J, Galani IE, Cerwenka A, Schirrmacher V, Fournier P.
    Vaccine; 2011 Feb 01; 29(6):1185-93. PubMed ID: 21172381
    [Abstract] [Full Text] [Related]

  • 34. A temperature-sensitive mutant of Newcastle disease virus which is affected in both haemagglutinin-neuraminidase and matrix proteins.
    Harper DR, Samson AC, Lee CM, Simon E.
    J Gen Virol; 1983 Dec 01; 64 ( Pt 12)():2781-4. PubMed ID: 6663286
    [Abstract] [Full Text] [Related]

  • 35. [Effect of modified NDV F48E9 strain HN gene and in vitro expression of its DNA vaccine].
    He S, Shi X, Wang Y, Wang M, Ran D, Tong G.
    Sheng Wu Gong Cheng Xue Bao; 2008 Feb 01; 24(2):226-31. PubMed ID: 18464605
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Transfection of the Newcastle disease virus hemagglutinin-neuraminidase gene into murine myeloma cells for induction of host-versus-tumor immune response.
    Risinskaya NV, Vasilenko OV, Fegeding KV, Sudarikov AB.
    Dokl Biochem Biophys; 2001 Feb 01; 378():217-20. PubMed ID: 11712185
    [No Abstract] [Full Text] [Related]

  • 38. Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy.
    Janke M, Peeters B, de Leeuw O, Moorman R, Arnold A, Fournier P, Schirrmacher V.
    Gene Ther; 2007 Dec 01; 14(23):1639-49. PubMed ID: 17914407
    [Abstract] [Full Text] [Related]

  • 39. [Role of intracellular proteinases and glycosidases in the degradation of the 'large glycoprotein' responsible for the neuraminidase and hemagglutinating activity of the Newcastle disease virus].
    Tsvetkova IV, Chemm LV.
    Vopr Med Khim; 1976 Dec 01; 22(2):266-9. PubMed ID: 1025889
    [Abstract] [Full Text] [Related]

  • 40. Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2.
    Janke M, Peeters B, Zhao H, de Leeuw O, Moorman R, Arnold A, Ziouta Y, Fournier P, Schirrmacher V.
    Int J Oncol; 2008 Oct 01; 33(4):823-32. PubMed ID: 18813797
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.